BioEcho Life Sciences
BioEcho Life Sciences is a Cologne, Germany-based developer of single-step nucleic acid purification kits using its proprietary EchoLUTION technology, serving agricultural biology, biopharmaceutical R&D, and academic research customers across Europe, Asia, and North America.
- Company typePrivate
- Founded2016
- HeadquartersCologne, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What BioEcho Life Sciences does
BioEcho Life Sciences is a Cologne, Germany-based developer and manufacturer of nucleic acid purification kits built around its proprietary EchoLUTION single-step purification technology. The company was founded in 2016 by Markus Muller and Frank Schaefer (both managing directors) and operates as a private, for-profit entity with 11-50 employees, co-branded as 'Bioecho_an_admera_company' indicating affiliation with Admera Health. Its product portfolio spans RNA Purification, DNA Purification, Nucleic Acid Cleanup, and Biochemical & Labware categories, with specialized kits for FFPE, plant, tissue, viral, and buccal swab samples. The EchoLUTION platform is positioned as a differentiated single-step alternative to legacy multi-step column-based kits, with manufacturer-stated performance advantages of approximately 5x faster processing, 57% lower per-sample cost, and throughput of 2,000 samples in under one hour; the technology has received third-party validation through an independent TAmiRNA study rating its FFPE RNA kit 11.5 out of 12.
The company sells kits via a one-time transactional revenue model with quote-based pricing and a free-trial entry point, distributed through a hybrid direct (company website) and third-party distributor channel — for example, Kem-En-Tec Nordic in the Nordic region. Its go-to-market is sales-led, and its customer base spans three principal end-markets: agricultural biology (e.g., Bejo Zaden, Chinese Academy of Tropical Agricultural Sciences), biopharmaceutical R&D, and academic research (e.g., Hudson Alpha, ISAS, Carlsberg Lab). Geographically, BioEcho claims active commercial coverage in Europe, Asia, and North America. To date the company has raised four funding rounds, including a 2022 round led by Ampersand Capital Partners, reflecting institutional investor engagement consistent with a scaling-stage life sciences tools business.
BioEcho Life Sciences firmographics
Firmographics- Name
- BioEcho Life Sciences
- Website
- https://bioecho.de
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BioEcho Life Sciences is a Cologne, Germany-based developer of single-step nucleic acid purification kits using its proprietary EchoLUTION technology, serving agricultural biology, biopharmaceutical R&D, and academic research customers across Europe, Asia, and North America.
- Ownership category
- akta.pro rank
BioEcho Life Sciences industry classification
Industry- Product category
- Life Sciences Reagents & Kits
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
Keywords
Where BioEcho Life Sciences is headquartered
LocationHeadquarters
- HQ city
- Cologne
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
BioEcho Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Nucleic Acid Purification Kits: Sale of RNA and DNA extraction/purification kits for various sample types including cell culture, tissue, FFPE, plant, buccal swab, and viral samples. Revenue generated through direct product sales and distributor network.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Product-based pricing for laboratory kits |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
BioEcho Life Sciences product offering
Product offeringCore offering
BioEcho Life Sciences develops and sells nucleic acid purification kits based on its proprietary EchoLUTION single-step technology. The product portfolio includes RNA extraction kits (cell culture, tissue, FFPE, viral), DNA extraction kits (FFPE, plant, tissue, buccal swab), nucleic acid cleanup reagents, and supporting biochemical labware. The kits are designed for research laboratories, replacing traditional 7-step bind-wash-elute silica protocols with a 3-step workflow that is faster, phenol- and chloroform-free, and scalable to 384-well high-throughput formats.
Product overview
BioEcho Life Sciences offers a unified product portfolio centered on EchoLUTION technology, a single-step nucleic acid purification platform that eliminates traditional bind-wash-elute steps. The product line includes RNA extraction kits (Cell Culture RNA, Tissue RNA, FFPE RNA, Viral RNA/DNA), DNA extraction kits (FFPE DNA, Plant DNA, Tissue DNA, Buccal Swab DNA), and nucleic acid cleanup products (EchoCLEAN RNA and DNA). The portfolio scales from individual sample processing to 96- and 384-well plate formats for high-throughput applications. Complementary biochemical reagents and laboratory accessories round out the offering for complete molecular biology workflow support.
Differentiator
Problem solved
Functional benefit
Brands
- EchoLUTION: Single-step nucleic acid purification technology that is phenol-free and chloroform-free, designed for faster, simpler, and more scalable RNA and DNA extraction workflows.
Products and services
- EchoLUTION Cell Culture RNA Kit RNA extraction kit designed for rapid purification of RNA from cell culture samples using the proprietary EchoLUTION single-step technology, enabling faster processing than traditional silica-based methods.
- EchoLUTION Tissue RNA Kit RNA extraction kit for purification from tissue samples, utilizing the EchoLUTION technology platform to streamline nucleic acid workflows.
- EchoLUTION FFPE RNA Kit RNA extraction kit specifically designed for Formalin-Fixed Paraffin-Embedded (FFPE) samples, achieving top performance ratings in independent TAmiRNA studies for lowest RNA degradation and highest miRNA read percentages.
- Viral RNA & DNA Extraction Kit Extraction kit enabling purification of both RNA and DNA from viral samples.
- EchoLUTION FFPE DNA Kit DNA extraction kit optimized for Formalin-Fixed Paraffin-Embedded (FFPE) tissue samples.
- EchoLUTION Plant DNA Kit DNA extraction kit designed for plant samples, enabling high-quality genomic DNA isolation from large input samples of difficult plant tissues with a streamlined workflow.
- EchoLUTION Tissue DNA Kit DNA extraction kit for purification from tissue samples using the EchoLUTION technology.
- EchoLUTION Buccal Swab DNA Kit DNA extraction kit for buccal swab samples, enabling non-invasive genetic material collection.
- EchoCLEAN RNA RNA cleanup reagent for nucleic acid purification and impurity removal following extraction workflows.
- EchoCLEAN DNA DNA cleanup reagent for nucleic acid purification and impurity removal following extraction workflows.
Quantifiable outcome
- 5x faster than traditional extraction methods
- +4 more outcomes
Companies that use BioEcho Life Sciences
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
BioEcho Life Sciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
BioEcho Life Sciences partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Kem-En-Tec NordiccoreRegional distributor for Nordic countries (Denmark, Sweden, Norway, Finland). Provides local sales, support, and automation setup assistance for BioEcho products including the Plant 96 kit. Collaborated on Cybio-Felix robot integration for Carlsberg Research Laboratory.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
BioEcho Life Sciences competitors and assessment
Company assessmentDirect peers
- Zymo Research: Zymo Research offers a broad portfolio of nucleic acid purification kits (Quick-DNA/RNA, Direct-zol) and competes head-to-head with BioEcho in DNA/RNA extraction and cleanup workflows across academic and applied research segments.
- Norgen Biotek: Norgen Biotek specializes in nucleic acid and protein purification kits, including plant, fecal, and exosome extraction, serving academic and applied research labs. Comparable size and product focus make it a direct peer in niche extraction chemistry.
- Omega Bio-tek: Omega Bio-tek manufactures E.Z.N.A. and Mag-Bind kits for DNA and RNA extraction from tissues, plants, blood, and FFPE. It is a similarly-sized specialty reagent vendor directly comparable on product scope and target customer profile.
- Macherey-Nagel: Germany-based manufacturer of NucleoSpin and NucleoMag kits for DNA/RNA purification from cells, tissues, FFPE, and plants. Like BioEcho, it serves molecular biology labs with single-step and high-throughput chemistries, making it a direct European competitor.
Broad incumbents
- QIAGEN: QIAGEN is the dominant global provider of nucleic acid sample preparation kits (RNeasy, DNeasy, QIAamp) that BioEcho explicitly benchmarks against. It is the most directly comparable incumbent and the primary competitive threat to EchoLUTION in research and molecular diagnostics workflows.
- Promega: Promega provides Maxwell and Wizard kits for automated and manual nucleic acid purification used in research, forensics, and clinical labs. It is a broader tools incumbent with overlapping reagent offerings and automation platforms.
- Beckman Coulter Life Sciences: Beckman Coulter provides SPRI-based nucleic acid purification reagents (AMPure XP) widely used in NGS workflows. It represents a broad incumbent competing in adjacent high-throughput sample preparation use cases.
- Thermo Fisher Scientific (Life Sciences Solutions): Thermo Fisher offers MagMAX, KingFisher, and PureLink kits for nucleic acid purification, supported by a massive installed base of automated extraction instruments. It is a broad incumbent whose reagent portfolio overlaps materially with EchoLUTION.
- PerkinElmer (Revvity chemagen): PerkinElmer (now Revvity) provides chemagen and prepito automated nucleic acid extraction solutions used in clinical and research settings. Its bead-based chemistries overlap with EchoLUTION's automation-ready positioning.
Emerging players
- LGC Biosearch Technologies: LGC Biosearch Technologies supplies sbeadex and other nucleic acid purification chemistries alongside genomics oligos and qPCR. Its sample-prep line directly competes with EchoLUTION kits in agricultural and clinical research workflows.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
BioEcho Life Sciences social profiles
Digital presenceBioEcho Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioEcho Life Sciences leadership team
Management profileNumber of profiles
Profiles2 records
BioEcho Life Sciences funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioEcho Life Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioEcho Life Sciences
What does BioEcho Life Sciences do?
BioEcho Life Sciences develops and sells nucleic acid purification kits based on its proprietary EchoLUTION single-step technology. The product portfolio includes RNA extraction kits (cell culture, tissue, FFPE, viral), DNA extraction kits (FFPE, plant, tissue, buccal swab), nucleic acid cleanup reagents, and supporting biochemical labware. The kits are designed for research laboratories, replacing traditional 7-step bind-wash-elute silica protocols with a 3-step workflow that is faster, phenol- and chloroform-free, and scalable to 384-well high-throughput formats.
When was BioEcho Life Sciences founded?
BioEcho Life Sciences was founded in 2016. It employs 11 to 50 people.
Where is BioEcho Life Sciences based?
BioEcho Life Sciences is headquartered in Cologne, Germany, in the Europe region.
How does BioEcho Life Sciences make money?
One revenue line is on record: nucleic Acid Purification Kits.
Who are BioEcho Life Sciences's main competitors?
Direct peers on record are Zymo Research, Norgen Biotek, Omega Bio-tek and Macherey-Nagel. Broad incumbents are QIAGEN, Promega, Beckman Coulter Life Sciences, Thermo Fisher Scientific (Life Sciences Solutions) and PerkinElmer (Revvity chemagen). LGC Biosearch Technologies is listed as an emerging player.
Does BioEcho Life Sciences have an API?
No public API is recorded for BioEcho Life Sciences.
What industry is BioEcho Life Sciences in?
BioEcho Life Sciences's product category is Life Sciences Reagents & Kits. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325414 and its SIC code is 2836.